Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study-Reference-Cited by-同舟云学术

Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study

Published:2023-10 Issue:10 Volume:29 Page:1298-1305
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Manesh Abi,Devasagayam Emily,Bhanuprasad Kundakarla,Varghese Lalee,Kurien Regi,Cherian Lisa M.,Dayanand Divya,George Mithun M.,Kumar Selwyn S.,Karthik Rajiv,Vanjare Harshad,Peter Jayanthi,Michael Joy S.,Thomas Meera,Mathew Binu S.,Samuel Prasanna,Peerawaranun Pimnara,Mukaka Mavuto,Rupa Vedantam,Varghese George M.

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Christian Medical College, Vellore

The Wellcome Trust DBT India Alliance

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference21 articles.

1. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic;Bhanuprasad;Int J Infect Dis,2021

2. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium;Cornely;Lancet Infect Dis,2019

3. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries;Rudramurthy;Mycoses,2021